As of January 22, 2025, Jasper Therapeutics (JSPR) has a market cap of $90.158 million USD. According to our data, Jasper Therapeutics is ranked No.7763 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $90.16 M |
-71.89%
|
Dec 31, 2024 | $0.32 B |
170.98%
|
Dec 29, 2023 | $0.12 B |
63.35%
|
Dec 30, 2022 | $72.46 M |
-93.85%
|
Dec 31, 2021 | $1.18 B |
-21.58%
|
Dec 31, 2020 | $1.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Market Cap | = | JSPR Stock Price | * | JSPR Shares Outstanding |
= | $6.01 | * | 15.00 M | |
= | $90.16 M |